Protective effect of 4-methoxy-5-hydroxycanthin-6-one, a natural alkaloid, on dextran sulfate sodium-induced rat colitis

Planta Medica

Volumn 75, Issue 2, 2009, Pages 142-145

  Liu, Jun Feng ^a,c   Shao, Meng ^b,c   Zhai, Da Wei ^c   Liu, Ke ^d   Wu, Li Jun ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c Shandong Target Drug Research Co Ltd   (China)

^d YANTAI UNIVERSITY   (China)

Author keywords

4 methoxy 5 hydroxycanthin 6 one; DSS; MPO; Picrasma quassioides (D. Don) Benn.; Simaroubaceae; TNF ; Ulcerative colitis

Indexed keywords

4 METHOXY 5 HYDROXYCANTHIN 6 ONE; ALKALOID DERIVATIVE; DEXTRAN SULFATE; MYELOPEROXIDASE; PICRASMA QUASSIOIDES EXTRACT; SALAZOSULFAPYRIDINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4-METHOXY-5-HYDROXYCANTHIN-6-ONE; INDOLE DERIVATIVE; NAPHTHYRIDINE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON LENGTH; COLON MUCOSA; CONTROLLED STUDY; DIARRHEA; FECES ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PICRASMA; PICRASMA QUASSIOIDES; RAT; TREATMENT OUTCOME; ULCERATIVE COLITIS; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COLON; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; INTESTINE MUCOSA; LETTER; METABOLISM; PATHOLOGY; PHYTOTHERAPY; WISTAR RAT;

PICRASMA QUASSIOIDES; RATTUS; SIMAROUBACEAE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; INDOLES; INTESTINAL MUCOSA; NAPHTHYRIDINES; PEROXIDASE; PHYTOTHERAPY; PICRASMA; PLANT EXTRACTS; RATS; RATS, WISTAR; SULFASALAZINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63149110900     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0028-1088390     Document Type: Article

References (19)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429
2. Egger B, Bajaj-Elliott M, MacDonald TT, Lnglin R, Eysselein VE, Buchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000; 62: 240-248 (Pubitemid 30825398)
3. Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-249
4. Pharmacopoeia of China, Part I. Beijing: Chemical Industry Press; 2005: 139
5. Chen M, Fan HY, Dai SJ, Liu K. Alkaloids from twigs and leaves of Picrasma quassioides. Chin Tradit Herb Drugs 2007; 6: 807-810
6. Yang JX. Picrasma quassioides (D.Don) Benn. In: Song ZY, editor. Modern research of traditional Chinese herbs. Beijing: Beijing Medical University & Beijing Union Medical College Press; 1996: 498-522
7. Sung YIK, Koike K, Nikaido T, Ohmoto T, Sankawa U. Inhibitors of cyclic AMP phosphodiesterase in medicinal plants. V. Inhibitors of cyclic AMP phosphodiesterase in Picrasma quassioides Bennet, and inhibitory activities of related β-carboline alkaloids. Chem Pharm Bull 1984; 32: 1872-1877 (Pubitemid 14111358)
8. Ohmoto T, Sung YIK, Koike K. Effect of alkaloids of simaroubaceous plants on the local blood flow rate. Shoyakugaku Zasshi 1985; 39: 28-34
9. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702 (Pubitemid 20069706)
10. Mahler M, Bristol IJ, Leiter EH,Workman AE, Birkenmeier EH, Elson CO et al. Differential susceptibility of inbred mouse strain to dextran sulfate sodium-induced colitis. Am J Physiol 1998; 274: 544-551 (Pubitemid 28160553)
11. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2: 541-546 (Pubitemid 47040018)
12. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803
13. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989; 97: 326-337 (Pubitemid 19192168)
14. John D. Chinese Herbal, Part V. Shanghai: Scientific & Technical Publishers; 1999: 13-16
15. D'Haens G. Anti-TNF therapy for Crohn's disease. Curr Pharm Des 2003; 9: 289-294
16. Murata Y, Ishiguro Y, Itou J. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 1995; 30: 56-60
17. Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon- gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116: 238-245 (Pubitemid 29219719)
18. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984; 87: 1344-1350
19. Porter SN, Howarth GS, Butler RN. An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitis rats. Scand J Gastroenterol 1998; 33: 967-974